Literature DB >> 22491684

Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.

Hsih-Yeh Tsai1, Chun-Hsing Liao, Yen-Hsu Chen, Po-Liang Lu, Cheng-Hua Huang, Chin-Te Lu, Yin-Ching Chuang, Shih-Ming Tsao, Yao-Shen Chen, Yung-Ching Liu, Wei-Yu Chen, Tsrang-Neng Jang, Hsiu-Chen Lin, Chih-Ming Chen, Zhi-Yuan Shi, Sung-Ching Pan, Jia-Ling Yang, Hsiang-Chi Kung, Chun-Eng Liu, Yu-Jen Cheng, Jien-Wei Liu, Wu Sun, Lih-Shinn Wang, Wen-Chien Ko, Kwok-Woon Yu, Ping-Cherng Chiang, Ming-Hsun Lee, Chun-Ming Lee, Gwo-Jong Hsu, Po-Ren Hsueh.   

Abstract

Among the 219 vancomycin-resistant Enterococcus faecium isolates collected in 20 Taiwanese hospitals from 2006 to 2010, all were susceptible to linezolid and daptomycin, and 98.6% were susceptible to tigecycline. There was a shift toward higher tigecycline MIC values (MIC(90)s) from 2006-2007 (0.06 μg/ml) to 2008-2010 (0.12 μg/ml). The MIC(90)s of daptomycin and linezolid remained stationary. Although pulsotypes among the isolates from the 20 hospitals varied, intrahospital spreading of several clones was identified in 13 hospitals.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22491684      PMCID： PMC3370810          DOI： 10.1128/AAC.00533-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Vancomycin-resistant enterococcal infections.

Authors:  B E Murray
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

Review 2.  Vancomycin-resistant enterococci.

Authors:  Y Cetinkaya; P Falk; C G Mayhall
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones.

Authors:  P R Hsueh; L J Teng; H J Pan; Y C Chen; L H Wang; S C Chang; S W Ho; K T Luh
Journal:  Infect Control Hosp Epidemiol       Date:  1999-12       Impact factor: 3.254

4.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

5.  Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.

Authors:  Yen-Hsu Chen; Po-Liang Lu; Cheng-Hua Huang; Chun-Hsing Liao; Chin-Te Lu; Yin-Ching Chuang; Shih-Ming Tsao; Yao-Shen Chen; Yung-Ching Liu; Wei-Yu Chen; Tsrang-Neng Jang; Hsiu-Chen Lin; Chih-Ming Chen; Zhi-Yuan Shi; Sung-Ching Pan; Jia-Ling Yang; Hsiang-Chi Kung; Chun-Eng Liu; Yu-Jen Cheng; Jien-Wei Liu; Wu Sun; Lih-Shinn Wang; Wen-Chien Ko; Kwok-Woon Yu; Ping-Cherng Chiang; Ming-Hsun Lee; Chun-Ming Lee; Gwo-Jong Hsu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-12-27       Impact factor: 5.191

Review 6.  The life and times of the Enterococcus.

Authors:  B E Murray
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

7.  Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan.

Authors:  R J Ben; J J Lu; T G Young; W M Chi; C C Wang; M L Chu; J C Wang
Journal:  J Formos Med Assoc       Date:  1996-12       Impact factor: 3.282

Review 8.  Vancomycin-resistant enterococci: why are they here, and where do they come from?

Authors:  M J Bonten; R Willems; R A Weinstein
Journal:  Lancet Infect Dis       Date:  2001-12       Impact factor: 25.071

9.  Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.

Authors:  M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; P C De Girolami; M J Ferraro; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents.

Authors:  Po-Ren Hsueh; Wen-Huei Chen; Lee-Jene Teng; Kwen-Tay Luh
Journal:  Int J Antimicrob Agents       Date:  2005-07       Impact factor: 5.283
View more
  11 in total

1.  Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.

Authors:  Y-H Chen; C-Y Liu; W-C Ko; C-H Liao; P-L Lu; C-H Huang; C-T Lu; Y-C Chuang; S-M Tsao; Y-S Chen; Y-C Liu; W-Y Chen; T-N Jang; H-C Lin; C-M Chen; Z-Y Shi; S-C Pan; J-L Yang; H-C Kung; C-E Liu; Y-J Cheng; J-W Liu; W Sun; L-S Wang; K-W Yu; P-C Chiang; M-H Lee; C-M Lee; G-J Hsu; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-18       Impact factor: 3.267

2.  Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds.

Authors:  Sebastian Schmidt; Markus M Heimesaat; André Fischer; Stefan Bereswill; Matthias F Melzig
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-12-16

3.  In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.

Authors:  Ko-Hung Chen; Yu-Tsung Huang; Chun-Hsing Liao; Wang-Hui Sheng; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

4.  Histopathological changes induced in an animal model by potentially pathogenic Enterococcus faecalis strains recovered from ready-to-eat food outlets in Osun State, Nigeria.

Authors:  Adetunji Kola Olawale; Oluwole Moses David; Adekemi Olubukunola Oluyege; Richard Temitope Osuntoyinbo; Solomon Anjuwon Laleye; Oladiran Famurewa
Journal:  Infect Drug Resist       Date:  2015-06-26       Impact factor: 4.003

5.  Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital.

Authors:  Sofia Maraki; George Samonis; Dimitra Dimopoulou; Elpis Mantadakis
Journal:  Infect Chemother       Date:  2014-12-29

6.  Study of vancomycin and high-level aminoglycoside-resistant Enterococcus species and evaluation of a rapid spot test for enterococci from Central Referral Hospital, Sikkim, India.

Authors:  Tsering Yangzom; T Shanti Kumar Singh
Journal:  J Lab Physicians       Date:  2019 Jul-Sep

7.  Characterization of Vancomycin Resistant Enterococci in Hospitalized Patients and Role of Gut Colonization.

Authors:  Geetarani Purohit; Rajni Gaind; Reetika Dawar; P K Verma; K C Aggarwal; Raman Sardana; Monorama Deb
Journal:  J Clin Diagn Res       Date:  2017-09-01

Review 8.  Intrinsic and acquired resistance mechanisms in enterococcus.

Authors:  Brian L Hollenbeck; Louis B Rice
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

9.  Characterization of aminoglycoside resistance and virulence genes among Enterococcus spp. isolated from a hospital in China.

Authors:  Wanxiang Li; Jing Li; Quhao Wei; Qingfeng Hu; Xiaowei Lin; Mengquan Chen; Renji Ye; Huoyang Lv
Journal:  Int J Environ Res Public Health       Date:  2015-03-11       Impact factor: 3.390

10.  Vancomycin-resistant enterococcal infection in a Thai university hospital: clinical characteristics, treatment outcomes, and synergistic effect.

Authors:  Jatapat Hemapanpairoa; Dhitiwat Changpradub; Sudaluck Thunyaharn; Wichai Santimaleeworagun
Journal:  Infect Drug Resist       Date:  2019-07-11       Impact factor: 4.003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.